美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

203.77

+0.42000.21%

盤後：203.770.00000.00%19:51 EDT

成交量：137.87萬

成交額：2.79億

市值：436.75億

市盈率：-22.84

高：206.36

開：204.98

低：197.81

收：203.35

52周最高：224.31

52周最低：42.18

股本：2.14億

流通股本：1.85億

量比：1.07

換手率：0.75%

股息：- -

股息率：- -

每股收益(TTM):-8.9212

每股收益(LYR):-5.9502

淨資產收益率：-79.09%

總資產收益率：-30.12%

市淨率：16.76

市盈率(LYR):-34.25

資料載入中...

總覽公司新聞公告

百濟神州與Revolution Medicines宣佈合作；甘李藥業宣佈減肥新藥海外BD | 醫藥早參

每日经济新闻

百濟神州獲Revolution Medicines四大資產在選定亞洲市場的獨家授權

百濟神州與Revolution Medicines合作：里程碑付款與分級版税權益

根據美國證券交易委員會文件披露，谷歌母公司Alphabet Inc.將其持有Revolution Medicines I

Revolution Medicines 2026年第二季度財報：研發投入推高淨虧損

TradingKey中文

異動解讀｜Revolution Medicines盤中上漲5.23%，FDA受理新藥申請疊加財報前市場預期升温

傑富瑞因索馬圖林面臨的競爭風險，將伊普森評級下調至「表現遜於大盤」

異動解讀｜Revolution Medicines盤中上漲5.02%，FDA受理胰腺癌新藥上市申請疊加投行上調目標價

異動解讀｜Revolution Medicines盤中上漲5.06%，核心藥物NDA獲FDA正式受理

Revolution Medicines新藥Daraxonrasib獲FDA受理，用於既往治療過的轉移性胰腺癌

異動解讀｜Revolution Medicines盤前下跌5.11%，報172.36美元

歐洲藥品管理局啓動分階段審評，加速評估Revolution Medicines的Daraxonrasib

歐洲藥品管理局（EMA）對Revolution Medicines實驗性胰腺癌口服藥啓動滾動審查

歐盟監管機構開始對一種抗癌藥物進行分階段審查，Revolution Medicines股價上漲

異動解讀｜Revolution Medicines盤中上漲5.07%，ESMO GI數據亮眼疊加收入預期上調

異動解讀｜Revolution Medicines盤中上漲5.91%，啓動Zoldonrasib聯合化療一線胰腺癌三期試驗疊加投行看好收入增長

Revolution Medicines啓動Rasolute 305患者治療，評估Zoldonrasib聯合化療作為Ras G12d轉移性胰腺癌一線療法

媒體-抗癌藥物製造商Revolution Medicines表示，出售公司並非當務之急——《金融時報》

媒體-抗癌藥物製造商Revolution Medicines表示，出售公司並非當務之急——《金融時報》

異動解讀｜Revolution Medicines盤中下跌5.21%，報142.19美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/RVMD/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RVMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVMD\",,,,,undefined,":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":203.77,"timestamp":1789156800000,"preClose":203.35,"halted":0,"volume":1378678,"hourTrading":{"tag":"盘后","latestPrice":203.77,"preClose":203.77,"latestTime":"19:51 EDT","volume":18305,"amount":3730090.65,"timestamp":1789170683594,"change":0,"changeRate":0,"amplitude":0.001963},"delay":0,"changeRate":0.0020654044750431076,"floatShares":185000000,"shares":214336418,"eps":-8.921187,"marketStatus":"休市中","change":0.42,"latestTime":"09-11 16:00:00 EDT","open":204.98,"high":206.36,"low":197.8125,"amount":279188540.41134,"amplitude":0.042033,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.921187,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":203.35,"preHourTrading":{"tag":"盘前","latestPrice":204.6041,"preClose":203.35,"latestTime":"09:25 EDT","volume":214,"amount":43809.79324,"timestamp":1789133126956,"change":1.2541,"changeRate":0.006167,"amplitude":0.022868},"postHourTrading":{"tag":"盘后","latestPrice":203.77,"preClose":203.77,"latestTime":"19:51 EDT","volume":18305,"amount":3730090.65,"timestamp":1789170683594,"change":0,"changeRate":0,"amplitude":0.001963},"volumeRatio":1.071573416960933,"optionData":{"bulkOrders":[{"symbol":"RVMD","call":true,"expireDate":1789704000000,"strike":"200.0","timestamp":1789140395642,"price":5.5,"volume":2000,"amount":1100000,"type":"+"},{"symbol":"RVMD","call":true,"expireDate":1789704000000,"strike":"200.0","timestamp":1789140395506,"price":5.4,"volume":2000,"amount":1080000,"type":"+"}]},"impliedVol":0.4301,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVMD\",,,,,undefined,":{"symbol":"RVMD","floatShares":185000000,"roa":"-30.12%","roe":"-79.09%","lyrEps":-5.950171,"volumeRatio":1.071573416960933,"shares":214336418,"dividePrice":0,"high":206.36,"amplitude":0.042033,"preClose":203.35,"low":197.8125,"week52Low":42.18,"pbRate":"16.76","psRate":"58861.63","week52High":224.31,"institutionHeld":0,"latestPrice":203.77,"eps":-8.921187,"divideRate":0,"volume":1378678,"delay":0,"ttmEps":-8.921187,"open":204.98,"prevYearClose":79.65,"prevWeekClose":210.02,"prevMonthClose":205.57,"prevQuarterClose":187.28,"fiveDayClose":210.87,"twentyDayClose":202,"sixtyDayClose":156.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RVMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"RVMD","fiscalQuarterEnding":"2026/06","expectedEps":-1.93,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-2.34},{"market":"US","date":"2026-05-06","symbol":"RVMD","fiscalQuarterEnding":"2026/03","expectedEps":-1.83,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2026-02-25","symbol":"RVMD","fiscalQuarterEnding":"2025/12","expectedEps":-1.56,"name":null,"time":"盤後","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2025-11-05","symbol":"RVMD","fiscalQuarterEnding":"2025/09","expectedEps":-1.39,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-1.61},{"market":"US","date":"2025-08-06","symbol":"RVMD","fiscalQuarterEnding":"2025/06","expectedEps":-0.94,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-1.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RVMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RVMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5909,"hold":0.0455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5909,"analysts":22,"updateTime":1789099200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RVMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RVMD","date":"2026-09-11","current":-22.841131,"percent":0.058776,"low":-29.983875,"twenty":-15.644447,"median":-11.807302,"eighty":-9.155597,"high":-5.200973,"avg":-13.025649,"sd":5.07755,"marketCap":43585310600},"quantilePoints":[{"date":"2021-09-17","current":-16.080727,"twenty":-34.931292,"median":-29.401065,"eighty":-19.128837,"marketCap":2297935941},{"date":"2021-09-24","current":-15.812973,"twenty":-34.786478,"median":-29.374181,"eighty":-19.029603,"marketCap":2259673799},{"date":"2021-10-01","current":-14.994261,"twenty":-34.755446,"median":-29.335032,"eighty":-18.644341,"marketCap":2142679943},{"date":"2021-10-08","current":-14.304278,"twenty":-34.745047,"median":-29.310402,"eighty":-18.527595,"marketCap":2044081346},{"date":"2021-10-15","current":-13.8769,"twenty":-34.734758,"median":-29.247595,"eighty":-18.445873,"marketCap":1983009081},{"date":"2021-10-22","current":-14.05712,"twenty":-34.714071,"median":-29.125884,"eighty":-18.095635,"marketCap":2008762446},{"date":"2021-10-29","current":-15.153884,"twenty":-34.648998,"median":-29.017933,"eighty":-17.885492,"marketCap":2165490066},{"date":"2021-11-05","current":-17.352562,"twenty":-34.580278,"median":-28.958078,"eighty":-17.646163,"marketCap":2479681115},{"date":"2021-11-12","current":-14.346829,"twenty":-34.492308,"median":-28.914638,"eighty":-17.476881,"marketCap":2419147952},{"date":"2021-11-19","current":-13.000858,"twenty":-34.414098,"median":-28.85313,"eighty":-17.352562,"marketCap":2192191641},{"date":"2021-11-26","current":-11.807838,"twenty":-34.412604,"median":-28.801275,"eighty":-17.20603,"marketCap":1991025820},{"date":"2021-12-03","current":-11.405795,"twenty":-34.3029,"median":-28.497349,"eighty":-17.023962,"marketCap":1923233675},{"date":"2021-12-10","current":-10.763399,"twenty":-34.187789,"median":-28.442942,"eighty":-16.776035,"marketCap":1814913617},{"date":"2021-12-17","current":-11.305284,"twenty":-34.083597,"median":-28.405363,"eighty":-16.474835,"marketCap":1906285639},{"date":"2021-12-23","current":-12.03945,"twenty":-34.013007,"median":-28.38164,"eighty":-16.42397,"marketCap":2030079990},{"date":"2021-12-31","current":-10.999381,"twenty":-33.942417,"median":-28.201619,"eighty":-16.346779,"marketCap":1854704659},{"date":"2022-01-07","current":-10.024863,"twenty":-33.76864,"median":-28.048463,"eighty":-16.058071,"marketCap":1690382395},{"date":"2022-01-14","current":-11.453865,"twenty":-33.634734,"median":-27.953181,"eighty":-15.823646,"marketCap":1931339257},{"date":"2022-01-21","current":-9.924352,"twenty":-33.600309,"median":-27.927252,"eighty":-15.745005,"marketCap":1673434358},{"date":"2022-01-28","current":-8.683262,"twenty":-33.572919,"median":-27.803555,"eighty":-15.342342,"marketCap":1464162955},{"date":"2022-02-04","current":-9.321287,"twenty":-33.538069,"median":-27.527148,"eighty":-15.221853,"marketCap":1571746141},{"date":"2022-02-11","current":-9.382468,"twenty":-33.35472,"median":-27.507196,"eighty":-14.988082,"marketCap":1582062337},{"date":"2022-02-18","current":-8.687632,"twenty":-33.099087,"median":-27.430755,"eighty":-14.738865,"marketCap":1464899826},{"date":"2022-02-25","current":-8.661412,"twenty":-33.042596,"median":-27.356123,"eighty":-14.46596,"marketCap":1460478599},{"date":"2022-03-04","current":-6.864099,"twenty":-32.958086,"median":-27.106898,"eighty":-14.327964,"marketCap":1284211088},{"date":"2022-03-11","current":-7.994236,"twenty":-32.941769,"median":-26.996531,"eighty":-14.248668,"marketCap":1495649655},{"date":"2022-03-18","current":-8.121129,"twenty":-32.904507,"median":-26.81427,"eighty":-14.145685,"marketCap":1519390126},{"date":"2022-03-25","current":-9.647806,"twenty":-32.821938,"median":-26.630154,"eighty":-14.012701,"marketCap":1805017664},{"date":"2022-04-01","current":-10.171238,"twenty":-32.790169,"median":-26.321811,"eighty":-13.877367,"marketCap":1902947106},{"date":"2022-04-08","current":-9.707287,"twenty":-32.696096,"median":-25.809173,"eighty":-13.834677,"marketCap":1816146010},{"date":"2022-04-14","current":-9.552636,"twenty":-32.655638,"median":-25.508846,"eighty":-13.634891,"marketCap":1787212311},{"date":"2022-04-22","current":-8.48198,"twenty":-32.605595,"median":-25.411043,"eighty":-13.186917,"marketCap":1586902089},{"date":"2022-04-29","current":-7.923582,"twenty":-32.604969,"median":-25.251002,"eighty":-13.000858,"marketCap":1482430833},{"date":"2022-05-06","current":-6.745162,"twenty":-32.556286,"median":-25.104297,"eighty":-12.432753,"marketCap":1261959147},{"date":"2022-05-13","current":-5.605175,"twenty":-32.548789,"median":-24.984266,"eighty":-12.03945,"marketCap":1163421328},{"date":"2022-05-20","current":-5.626637,"twenty":-32.521167,"median":-24.877571,"eighty":-11.729177,"marketCap":1167876036},{"date":"2022-05-27","current":-6.045147,"twenty":-32.510824,"median":-24.637509,"eighty":-11.453865,"marketCap":1254742849},{"date":"2022-06-03","current":-6.842821,"twenty":-32.499218,"median":-24.219623,"eighty":-11.34811,"marketCap":1420309509},{"date":"2022-06-10","current":-6.406425,"twenty":-32.436346,"median":-23.895094,"eighty":-11.243229,"marketCap":1329730439},{"date":"2022-06-17","current":-6.442195,"twenty":-32.379374,"median":-23.366068,"eighty":-11.125239,"marketCap":1337154953},{"date":"2022-06-24","current":-6.749818,"twenty":-32.364381,"median":-23.214917,"eighty":-10.925091,"marketCap":1401005772},{"date":"2022-07-01","current":-7.472374,"twenty":-32.356442,"median":-22.940713,"eighty":-10.752911,"marketCap":1550980953},{"date":"2022-07-08","current":-8.373781,"twenty":-32.351591,"median":-22.671372,"eighty":-10.549267,"marketCap":1738078703},{"date":"2022-07-15","current":-8.334434,"twenty":-32.34811,"median":-22.432492,"eighty":-10.427254,"marketCap":1729911738},{"date":"2022-07-22","current":-9.416787,"twenty":-32.336859,"median":-20.395581,"eighty":-10.154349,"marketCap":1954567219},{"date":"2022-07-29","current":-9.517907,"twenty":-32.317101,"median":-20.179552,"eighty":-10.138472,"marketCap":1975555860},{"date":"2022-08-05","current":-10.524893,"twenty":-32.295373,"median":-19.937304,"eighty":-10.061207,"marketCap":2184567746},{"date":"2022-08-12","current":-9.934512,"twenty":-32.249624,"median":-19.823476,"eighty":-9.887644,"marketCap":2230148976},{"date":"2022-08-19","current":-8.821128,"twenty":-32.202462,"median":-19.563716,"eighty":-9.821893,"marketCap":1980210927},{"date":"2022-08-26","current":-8.305455,"twenty":-32.188128,"median":-19.268933,"eighty":-9.766873,"marketCap":1864450146},{"date":"2022-09-02","current":-8.336708,"twenty":-32.148872,"median":-19.152186,"eighty":-9.713705,"marketCap":1871465951},{"date":"2022-09-09","current":-8.446093,"twenty":-32.08878,"median":-19.105488,"eighty":-9.655919,"marketCap":1896021268},{"date":"2022-09-16","current":-7.899168,"twenty":-32.064554,"median":-19.029603,"eighty":-9.51714,"marketCap":1773244683},{"date":"2022-09-23","current":-7.199884,"twenty":-32.002117,"median":-18.761088,"eighty":-9.470081,"marketCap":1616266049},{"date":"2022-09-30","current":-7.703837,"twenty":-31.933655,"median":-18.632667,"eighty":-9.406812,"marketCap":1729395902},{"date":"2022-10-07","current":-7.188165,"twenty":-31.892408,"median":-18.527595,"eighty":-9.339431,"marketCap":1613635122},{"date":"2022-10-14","current":-7.192071,"twenty":-31.843605,"median":-18.47506,"eighty":-9.283077,"marketCap":1614512098},{"date":"2022-10-21","current":-7.26239,"twenty":-31.799278,"median":-18.410849,"eighty":-9.19045,"marketCap":1630297658},{"date":"2022-10-28","current":-8.149191,"twenty":-31.791895,"median":-18.32329,"eighty":-9.019584,"marketCap":1829371122},{"date":"2022-11-04","current":-8.008553,"twenty":-31.779106,"median":-18.034343,"eighty":-8.822296,"marketCap":1797800000},{"date":"2022-11-11","current":-8.038796,"twenty":-31.743478,"median":-17.885492,"eighty":-8.744159,"marketCap":1968492013},{"date":"2022-11-18","current":-7.400623,"twenty":-31.611046,"median":-17.727885,"eighty":-8.684136,"marketCap":1812220207},{"date":"2022-11-25","current":-7.930016,"twenty":-31.608208,"median":-17.643244,"eighty":-8.652672,"marketCap":1941854774},{"date":"2022-12-02","current":-9.257124,"twenty":-31.600562,"median":-17.605302,"eighty":-8.582548,"marketCap":2266829098},{"date":"2022-12-09","current":-8.622578,"twenty":-31.589267,"median":-17.430183,"eighty":-8.622578,"marketCap":2111445200},{"date":"2022-12-16","current":-8.811129,"twenty":-31.528745,"median":-17.352562,"eighty":-8.622578,"marketCap":2157616415},{"date":"2022-12-23","current":-7.991658,"twenty":-31.520105,"median":-17.22743,"eighty":-8.579066,"marketCap":1956949209},{"date":"2022-12-30","current":-8.637082,"twenty":-31.479483,"median":-17.126643,"eighty":-8.567621,"marketCap":2114996832},{"date":"2023-01-06","current":-8.122193,"twenty":-31.410856,"median":-17.065386,"eighty":-8.466377,"marketCap":1988913897},{"date":"2023-01-13","current":-10.910571,"twenty":-31.358383,"median":-16.893151,"eighty":-8.452882,"marketCap":2671715141},{"date":"2023-01-20","current":-9.978694,"twenty":-31.337393,"median":-16.786158,"eighty":-8.462846,"marketCap":2443522788},{"date":"2023-01-27","current":-10.058466,"twenty":-31.313581,"median":-16.610494,"eighty":-8.476856,"marketCap":2463056764},{"date":"2023-02-03","current":-9.391286,"twenty":-31.29487,"median":-16.436017,"eighty":-8.510662,"marketCap":2299681694},{"date":"2023-02-10","current":-8.912656,"twenty":-31.274712,"median":-16.42397,"eighty":-8.560653,"marketCap":2182477839},{"date":"2023-02-17","current":-9.27888,"twenty":-31.260931,"median":-16.363929,"eighty":-8.574289,"marketCap":2272156546},{"date":"2023-02-24","current":-8.822007,"twenty":-31.242788,"median":-16.33277,"eighty":-8.579762,"marketCap":2160280139},{"date":"2023-03-03","current":-10.647267,"twenty":-31.197689,"median":-16.087084,"eighty":-8.579762,"marketCap":2648028624},{"date":"2023-03-10","current":-8.855897,"twenty":-31.16187,"median":-15.941671,"eighty":-8.590554,"marketCap":2202505834},{"date":"2023-03-17","current":-9.244089,"twenty":-31.149495,"median":-15.821867,"eighty":-8.624028,"marketCap":2299051129},{"date":"2023-03-24","current":-8.92415,"twenty":-31.112663,"median":-15.766631,"eighty":-8.630902,"marketCap":2219480831},{"date":"2023-03-31","current":-9.239823,"twenty":-31.043539,"median":-15.5066,"eighty":-8.63548,"marketCap":2297990191},{"date":"2023-04-06","current":-8.710858,"twenty":-31.019551,"median":-15.344402,"eighty":-8.63663,"marketCap":2166433966},{"date":"2023-04-14","current":-9.457381,"twenty":-30.941368,"median":-15.318656,"eighty":-8.637082,"marketCap":2352097994},{"date":"2023-04-21","current":-10.421462,"twenty":-30.878322,"median":-15.197652,"eighty":-8.651136,"marketCap":2591869823},{"date":"2023-04-28","current":-9.797218,"twenty":-30.870624,"median":-14.994261,"eighty":-8.652672,"marketCap":2436616994},{"date":"2023-05-05","current":-10.357181,"twenty":-30.85027,"median":-14.899002,"eighty":-8.661412,"marketCap":2575882625},{"date":"2023-05-12","current":-10.509705,"twenty":-30.781796,"median":-14.741954,"eighty":-8.675846,"marketCap":2723653028},{"date":"2023-05-17","current":-10.514164,"twenty":-30.750065,"median":-14.680164,"eighty":-8.680978,"marketCap":2724808597},{"date":"2023-05-22","current":-10.604414,"twenty":-30.742758,"median":-14.638971,"eighty":-8.681739,"marketCap":2748197512},{"date":"2023-06-02","current":-10.337765,"twenty":-30.715961,"median":-14.433006,"eighty":-8.684136,"marketCap":2679093900},{"date":"2023-06-06","current":-10.592107,"twenty":-30.691594,"median":-14.417559,"eighty":-8.685884,"marketCap":2745008115},{"date":"2023-06-16","current":-10.313152,"twenty":-30.665151,"median":-14.343576,"eighty":-8.689125,"marketCap":2672715105},{"date":"2023-06-23","current":-10.243413,"twenty":-30.661,"median":-14.332598,"eighty":-8.692112,"marketCap":2654641852},{"date":"2023-06-30","current":-10.756199,"twenty":-30.642434,"median":-14.304278,"eighty":-8.695537,"marketCap":2787533415},{"date":"2023-07-07","current":-10.747994,"twenty":-30.599184,"median":-14.268235,"eighty":-8.696853,"marketCap":2785407150},{"date":"2023-07-14","current":-10.88337,"twenty":-30.571275,"median":-14.227042,"eighty":-8.700327,"marketCap":2820490522},{"date":"2023-07-21","current":-11.002336,"twenty":-30.55928,"median":-14.165252,"eighty":-8.70235,"marketCap":2851321365},{"date":"2023-07-28","current":-10.325458,"twenty":-30.54682,"median":-14.131782,"eighty":-8.703075,"marketCap":2675904502},{"date":"2023-08-04","current":-13.431201,"twenty":-30.534927,"median":-14.05712,"eighty":-8.706952,"marketCap":3480776375},{"date":"2023-08-11","current":-10.985831,"twenty":-30.490465,"median":-13.92878,"eighty":-8.714953,"marketCap":3254354629},{"date":"2023-08-18","current":-10.794196,"twenty":-30.453438,"median":-13.8769,"eighty":-8.732356,"marketCap":3197586283},{"date":"2023-08-25","current":-11.726573,"twenty":-30.358451,"median":-13.852085,"eighty":-8.737762,"marketCap":3473786122},{"date":"2023-09-01","current":-12.518909,"twenty":-30.291198,"median":-13.806045,"eighty":-8.744159,"marketCap":3708501401},{"date":"2023-09-08","current":-11.826075,"twenty":-30.284917,"median":-13.70183,"eighty":-8.748813,"marketCap":3503261994},{"date":"2023-09-15","current":-11.995599,"twenty":-30.253212,"median":-13.486971,"eighty":-8.748872,"marketCap":3553480147},{"date":"2023-09-22","current":-11.232745,"twenty":-30.224947,"median":-13.356839,"eighty":-8.756739,"marketCap":3327498460},{"date":"2023-09-29","current":-10.407241,"twenty":-30.203399,"median":-13.174045,"eighty":-8.762048,"marketCap":3082957891},{"date":"2023-10-06","current":-9.332812,"twenty":-30.16501,"median":-13.144804,"eighty":-8.77058,"marketCap":2764677471},{"date":"2023-10-13","current":-8.941174,"twenty":-30.134266,"median":-12.958889,"eighty":-8.792291,"marketCap":2648661710},{"date":"2023-10-20","current":-10.714629,"twenty":-30.114487,"median":-12.616295,"eighty":-8.800251,"marketCap":3174016099},{"date":"2023-10-27","current":-7.356147,"twenty":-30.095825,"median":-12.606316,"eighty":-8.795475,"marketCap":2179126225},{"date":"2023-11-03","current":-7.81429,"twenty":-30.060759,"median":-12.501235,"eighty":-8.752019,"marketCap":2314842775},{"date":"2023-11-10","current":-6.620103,"twenty":-30.047837,"median":-12.424237,"eighty":-8.737762,"marketCap":2193485193},{"date":"2023-11-17","current":-10.554208,"twenty":-30.030888,"median":-12.332162,"eighty":-8.737762,"marketCap":3496999768},{"date":"2023-11-24","current":-10.718109,"twenty":-30.000059,"median":-12.21303,"eighty":-8.742996,"marketCap":3551306118},{"date":"2023-12-01","current":-11.587279,"twenty":-29.985066,"median":-12.109842,"eighty":-8.748813,"marketCap":3839294334},{"date":"2023-12-08","current":-12.158448,"twenty":-29.940089,"median":-12.106157,"eighty":-8.748872,"marketCap":4028543733},{"date":"2023-12-15","current":-12.987885,"twenty":-29.936663,"median":-12.117213,"eighty":-8.756739,"marketCap":4303366774},{"date":"2023-12-22","current":-13.047485,"twenty":-29.882158,"median":-12.163415,"eighty":-8.760986,"marketCap":4323114537},{"date":"2023-12-29","current":-14.587158,"twenty":-29.867332,"median":-12.21303,"eighty":-8.765461,"marketCap":4833265092},{"date":"2024-01-05","current":-13.921622,"twenty":-29.865533,"median":-12.242539,"eighty":-8.77058,"marketCap":4612748400},{"date":"2024-01-12","current":-14.055722,"twenty":-29.805418,"median":-12.332162,"eighty":-8.792291,"marketCap":4657180868},{"date":"2024-01-19","current":-13.191519,"twenty":-29.796607,"median":-12.415721,"eighty":-8.798659,"marketCap":4370838299},{"date":"2024-01-26","current":-13.891822,"twenty":-29.785014,"median":-12.501235,"eighty":-8.808953,"marketCap":4602874519},{"date":"2024-02-02","current":-14.035856,"twenty":-29.698709,"median":-12.606316,"eighty":-8.816931,"marketCap":4650598280},{"date":"2024-02-09","current":-15.088793,"twenty":-29.677719,"median":-12.710562,"eighty":-8.820579,"marketCap":4999475434},{"date":"2024-02-16","current":-14.641791,"twenty":-29.659728,"median":-12.916919,"eighty":-8.821831,"marketCap":4851367208},{"date":"2024-02-23","current":-14.428224,"twenty":-29.635698,"median":-13.000858,"eighty":-8.824984,"marketCap":4780604389},{"date":"2024-03-01","current":-11.126124,"twenty":-29.60188,"median":-12.952402,"eighty":-8.830519,"marketCap":4855073227},{"date":"2024-03-08","current":-11.89982,"twenty":-29.567836,"median":-12.759417,"eighty":-8.846692,"marketCap":5192688564},{"date":"2024-03-15","current":-12.069655,"twenty":-29.549023,"median":-12.639,"eighty":-8.858457,"marketCap":5266799247},{"date":"2024-03-22","current":-12.239491,"twenty":-29.460095,"median":-12.548969,"eighty":-8.864302,"marketCap":5340909931},{"date":"2024-03-28","current":-11.971528,"twenty":-29.40149,"median":-12.518909,"eighty":-8.873697,"marketCap":5223979741},{"date":"2024-04-05","current":-11.375216,"twenty":-29.393986,"median":-12.428588,"eighty":-8.893019,"marketCap":4963768897},{"date":"2024-04-12","current":-14.119006,"twenty":-29.381608,"median":-12.432753,"eighty":-8.907079,"marketCap":6161068163},{"date":"2024-04-19","current":-13.522694,"twenty":-29.367289,"median":-12.501235,"eighty":-8.909315,"marketCap":5900857318},{"date":"2024-04-26","current":-13.8038,"twenty":-29.352329,"median":-12.548969,"eighty":-8.913841,"marketCap":6023522918},{"date":"2024-05-03","current":-15.311943,"twenty":-29.337105,"median":-12.639,"eighty":-8.919031,"marketCap":6681626470},{"date":"2024-05-10","current":-12.75881,"twenty":-29.319095,"median":-12.75881,"eighty":-8.93096,"marketCap":6178734201},{"date":"2024-05-17","current":-13.283471,"twenty":-29.310603,"median":-12.746886,"eighty":-8.953134,"marketCap":6432812990},{"date":"2024-05-24","current":-12.990478,"twenty":-29.296302,"median":-12.759417,"eighty":-8.972364,"marketCap":6290924835},{"date":"2024-05-31","current":-13.058616,"twenty":-29.274087,"median":-12.91212,"eighty":-8.97648,"marketCap":6323922080},{"date":"2024-06-07","current":-13.743401,"twenty":-29.260932,"median":-12.989182,"eighty":-8.986745,"marketCap":6655544397},{"date":"2024-06-14","current":-13.157416,"twenty":-29.219252,"median":-13.004106,"eighty":-8.995267,"marketCap":6371768086},{"date":"2024-06-21","current":-13.017733,"twenty":-29.194791,"median":-13.000858,"eighty":-9.004739,"marketCap":6304123733},{"date":"2024-06-28","current":-13.222147,"twenty":-29.125884,"median":-13.032609,"eighty":-9.005202,"marketCap":6403115469},{"date":"2024-07-05","current":-12.786065,"twenty":-29.10502,"median":-13.010919,"eighty":-9.05152,"marketCap":6191933099},{"date":"2024-07-12","current":-15.378709,"twenty":-29.046393,"median":-13.058616,"eighty":-9.07038,"marketCap":7447478286},{"date":"2024-07-19","current":-15.719398,"twenty":-29.008869,"median":-13.107958,"eighty":-9.073204,"marketCap":7612464513},{"date":"2024-07-26","current":-15.821605,"twenty":-28.971852,"median":-13.144804,"eighty":-9.075352,"marketCap":7661960381},{"date":"2024-08-02","current":-14.990324,"twenty":-28.959284,"median":-13.159294,"eighty":-9.078336,"marketCap":7259393988},{"date":"2024-08-09","current":-13.80176,"twenty":-28.952047,"median":-13.186917,"eighty":-9.088056,"marketCap":7165970654},{"date":"2024-08-16","current":-13.785675,"twenty":-28.923049,"median":-13.211799,"eighty":-9.110957,"marketCap":7157618707},{"date":"2024-08-23","current":-14.039833,"twenty":-28.913715,"median":-13.226286,"eighty":-9.122932,"marketCap":7289579472},{"date":"2024-08-30","current":-13.714896,"twenty":-28.889231,"median":-13.275208,"eighty":-9.148532,"marketCap":7120870140},{"date":"2024-09-06","current":-13.460738,"twenty":-28.865184,"median":-13.307173,"eighty":-9.155161,"marketCap":6988909375},{"date":"2024-09-13","current":-14.059136,"twenty":-28.85313,"median":-13.370657,"eighty":-9.170299,"marketCap":7299601809},{"date":"2024-09-20","current":-14.612493,"twenty":-28.822017,"median":-13.38788,"eighty":-9.180362,"marketCap":7586908791},{"date":"2024-09-27","current":-14.210344,"twenty":-28.733437,"median":-13.413244,"eighty":-9.183247,"marketCap":7378110112},{"date":"2024-10-04","current":-15.22376,"twenty":-28.584764,"median":-13.42888,"eighty":-9.201243,"marketCap":7904282782},{"date":"2024-10-11","current":-16.240393,"twenty":-28.493659,"median":-13.447869,"eighty":-9.21728,"marketCap":8432125842},{"date":"2024-10-18","current":-16.224307,"twenty":-28.47389,"median":-13.485962,"eighty":-9.231265,"marketCap":8423773895},{"date":"2024-10-25","current":-14.934213,"twenty":-28.453985,"median":-13.505779,"eighty":-9.2387,"marketCap":7753947734},{"date":"2024-11-01","current":-17.723519,"twenty":-28.43718,"median":-13.530841,"eighty":-9.239492,"marketCap":9202175369},{"date":"2024-11-08","current":-17.929605,"twenty":-28.426015,"median":-13.549208,"eighty":-9.239823,"marketCap":10167179992},{"date":"2024-11-15","current":-16.354387,"twenty":-28.402209,"median":-13.553351,"eighty":-9.241502,"marketCap":9273935025},{"date":"2024-11-22","current":-16.834962,"twenty":-28.388854,"median":-13.59382,"eighty":-9.243502,"marketCap":9546450439},{"date":"2024-11-29","current":-17.161279,"twenty":-28.382984,"median":-13.599077,"eighty":-9.247065,"marketCap":9731491769},{"date":"2024-12-06","current":-15.665191,"twenty":-28.352774,"median":-13.629525,"eighty":-9.253671,"marketCap":8883118675},{"date":"2024-12-13","current":-14.667989,"twenty":-28.272382,"median":-13.644118,"eighty":-9.256981,"marketCap":8317644509},{"date":"2024-12-20","current":-14.3584,"twenty":-28.187897,"median":-13.679939,"eighty":-9.258574,"marketCap":8142088804},{"date":"2024-12-27","current":-14.407283,"twenty":-28.146447,"median":-13.685233,"eighty":-9.26075,"marketCap":8169808126},{"date":"2025-01-03","current":-14.377953,"twenty":-28.06298,"median":-13.698466,"eighty":-9.26075,"marketCap":8153176533},{"date":"2025-01-10","current":-13.615387,"twenty":-28.039753,"median":-13.70032,"eighty":-9.275254,"marketCap":7720755112},{"date":"2025-01-17","current":-13.129822,"twenty":-28.012756,"median":-13.698121,"eighty":-9.281462,"marketCap":7445409848},{"date":"2025-01-24","current":-13.35794,"twenty":-27.974892,"median":-13.684981,"eighty":-9.284891,"marketCap":7574766684},{"date":"2025-01-31","current":-13.99667,"twenty":-27.938362,"median":-13.683094,"eighty":-9.286872,"marketCap":7936965823},{"date":"2025-02-07","current":-13.748999,"twenty":-27.927744,"median":-13.698121,"eighty":-9.305989,"marketCap":7796521259},{"date":"2025-02-14","current":-13.253657,"twenty":-27.900337,"median":-13.683094,"eighty":-9.312333,"marketCap":7515632130},{"date":"2025-02-21","current":-13.471999,"twenty":-27.549957,"median":-13.678462,"eighty":-9.312333,"marketCap":7639445101},{"date":"2025-02-28","current":-12.621558,"twenty":-27.43754,"median":-13.619774,"eighty":-9.312333,"marketCap":7574108901},{"date":"2025-03-07","current":-12.147553,"twenty":-27.052106,"median":-13.57987,"eighty":-9.305989,"marketCap":7289661512},{"date":"2025-03-14","current":-12.11967,"twenty":-26.733207,"median":-13.542742,"eighty":-9.305989,"marketCap":7272929313},{"date":"2025-03-21","current":-11.806765,"twenty":-26.048313,"median":-13.507846,"eighty":-9.305989,"marketCap":7085156853},{"date":"2025-03-28","current":-11.571311,"twenty":-25.490858,"median":-13.471999,"eighty":-9.305989,"marketCap":6943862726},{"date":"2025-04-04","current":-9.703172,"twenty":-25.218993,"median":-13.436152,"eighty":-9.305989,"marketCap":5822805370},{"date":"2025-04-11","current":-11.066325,"twenty":-25.002048,"median":-13.416495,"eighty":-9.312333,"marketCap":6640824004},{"date":"2025-04-17","current":-11.388525,"twenty":-24.776212,"median":-13.38788,"eighty":-9.312333,"marketCap":6834173863},{"date":"2025-04-25","current":-12.011238,"twenty":-23.795402,"median":-13.335128,"eighty":-9.305989,"marketCap":7207859649},{"date":"2025-05-02","current":-12.639005,"twenty":-22.971228,"median":-13.283471,"eighty":-9.305989,"marketCap":7584578134},{"date":"2025-05-09","current":-10.794078,"twenty":-22.46336,"median":-13.226286,"eighty":-9.305989,"marketCap":7528934128},{"date":"2025-05-16","current":-10.559076,"twenty":-20.181887,"median":-13.186917,"eighty":-9.305989,"marketCap":7365018689},{"date":"2025-05-23","current":-10.36146,"twenty":-19.835151,"median":-13.144804,"eighty":-9.305989,"marketCap":7227180707},{"date":"2025-05-30","current":-10.437569,"twenty":-19.477908,"median":-13.099382,"eighty":-9.305989,"marketCap":7280266957},{"date":"2025-06-06","current":-10.735327,"twenty":-19.114828,"median":-13.02228,"eighty":-9.305989,"marketCap":7487955268},{"date":"2025-06-13","current":-10.978341,"twenty":-18.869661,"median":-12.990478,"eighty":-9.305989,"marketCap":7657458733},{"date":"2025-06-20","current":-10.663224,"twenty":-18.562619,"median":-12.881458,"eighty":-9.299644,"marketCap":7437663031},{"date":"2025-06-27","current":-10.008957,"twenty":-18.463385,"median":-12.772741,"eighty":-9.299644,"marketCap":6981307549},{"date":"2025-07-03","current":-10.113106,"twenty":-18.297004,"median":-12.734961,"eighty":-9.299644,"marketCap":7053951891},{"date":"2025-07-11","current":-10.281346,"twenty":-17.976026,"median":-12.650637,"eighty":-9.299644,"marketCap":7171300444},{"date":"2025-07-18","current":-10.428222,"twenty":-17.795598,"median":-12.615234,"eighty":-9.299644,"marketCap":7273747593},{"date":"2025-07-25","current":-9.939525,"twenty":-17.635003,"median":-12.544605,"eighty":-9.299644,"marketCap":6932877987},{"date":"2025-08-01","current":-9.952877,"twenty":-17.510008,"median":-12.441797,"eighty":-9.299644,"marketCap":6942191364},{"date":"2025-08-08","current":-8.04536,"twenty":-17.386734,"median":-12.335246,"eighty":-9.28683,"marketCap":6533314990},{"date":"2025-08-15","current":-8.29167,"twenty":-17.227741,"median":-12.226287,"eighty":-9.258574,"marketCap":6733333503},{"date":"2025-08-22","current":-8.39756,"twenty":-17.114968,"median":-12.166195,"eighty":-9.240942,"marketCap":6819322771},{"date":"2025-08-29","current":-8.822272,"twenty":-16.963885,"median":-12.133612,"eighty":-9.215532,"marketCap":7164214506},{"date":"2025-09-05","current":-8.966145,"twenty":-16.825201,"median":-12.107278,"eighty":-9.160498,"marketCap":7281047750},{"date":"2025-09-12","current":-10.644276,"twenty":-16.632002,"median":-12.076403,"eighty":-9.165399,"marketCap":8643790705},{"date":"2025-09-19","current":-10.409476,"twenty":-16.360805,"median":-12.036866,"eighty":-9.165399,"marketCap":8453118851},{"date":"2025-09-26","current":-9.785644,"twenty":-16.298315,"median":-11.983563,"eighty":-9.165399,"marketCap":7946529906},{"date":"2025-10-03","current":-10.51997,"twenty":-16.17003,"median":-11.932203,"eighty":-9.165399,"marketCap":8542846783},{"date":"2025-10-10","current":-10.960796,"twenty":-16.019241,"median":-11.883373,"eighty":-9.165399,"marketCap":8900823841},{"date":"2025-10-17","current":-11.436151,"twenty":-15.923821,"median":-11.824165,"eighty":-9.165399,"marketCap":9286840879},{"date":"2025-10-24","current":-12.301689,"twenty":-15.827099,"median":-11.824165,"eighty":-9.165399,"marketCap":9989709673},{"date":"2025-10-31","current":-13.551655,"twenty":-15.764391,"median":-11.824165,"eighty":-9.165399,"marketCap":11004756895},{"date":"2025-11-07","current":-11.939877,"twenty":-15.679879,"median":-11.815047,"eighty":-9.165399,"marketCap":11473959202},{"date":"2025-11-14","current":-12.951315,"twenty":-15.574558,"median":-11.815047,"eighty":-9.165399,"marketCap":12445929045},{"date":"2025-11-21","current":-14.057749,"twenty":-15.418688,"median":-11.815047,"eighty":-9.165399,"marketCap":13509187973},{"date":"2025-11-28","current":-15.642968,"twenty":-15.380753,"median":-11.815047,"eighty":-9.165399,"marketCap":15032548036},{"date":"2025-12-05","current":-15.78781,"twenty":-15.364762,"median":-11.815047,"eighty":-9.165399,"marketCap":15171738296},{"date":"2025-12-12","current":-15.793845,"twenty":-15.364762,"median":-11.815047,"eighty":-9.165399,"marketCap":15177537890},{"date":"2025-12-19","current":-15.280862,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":14684572387},{"date":"2025-12-26","current":-16.332981,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":15695634967},{"date":"2026-01-02","current":-16.023179,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":15397922468},{"date":"2026-01-09","current":-21.603631,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":20760613858},{"date":"2026-01-16","current":-24.798208,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":23830532362},{"date":"2026-01-23","current":-23.90099,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":22968326032},{"date":"2026-01-30","current":-19.75488,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18984004851},{"date":"2026-02-06","current":-19.342482,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18587699250},{"date":"2026-02-13","current":-19.579862,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18815816620},{"date":"2026-02-20","current":-20.668191,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19861676765},{"date":"2026-02-27","current":-17.788098,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":20123693112},{"date":"2026-03-06","current":-17.454238,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19745997277},{"date":"2026-03-13","current":-16.653698,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18840344852},{"date":"2026-03-20","current":-17.392928,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19676636588},{"date":"2026-03-27","current":-16.327876,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":18471742334},{"date":"2026-04-02","current":-17.279065,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19547823880},{"date":"2026-04-10","current":-16.855147,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":19068244259},{"date":"2026-04-17","current":-27.750933,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":31394658062},{"date":"2026-04-24","current":-25.001309,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":28284006272},{"date":"2026-05-01","current":-26.793491,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":30311503450},{"date":"2026-05-08","current":-22.086858,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":30296565868},{"date":"2026-05-15","current":-23.165977,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":31776793175},{"date":"2026-05-22","current":-23.826223,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":32682454103},{"date":"2026-05-29","current":-23.965712,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":32873790919},{"date":"2026-06-05","current":-24.129999,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":33099143168},{"date":"2026-06-12","current":-23.12878,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":31725770024},{"date":"2026-06-18","current":-24.452372,"twenty":-15.362099,"median":-11.815047,"eighty":-9.165399,"marketCap":33541343809},{"date":"2026-06-26","current":-27.614117,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":37878311634},{"date":"2026-07-02","current":-29.0617,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":39863962589},{"date":"2026-07-10","current":-29.622754,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":40633561782},{"date":"2026-07-17","current":-27.770654,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":38093034061},{"date":"2026-07-24","current":-29.253884,"twenty":-15.360619,"median":-11.807838,"eighty":-9.160498,"marketCap":40127582202},{"date":"2026-07-31","current":-29.783941,"twenty":-15.3547,"median":-11.807302,"eighty":-9.155597,"marketCap":40854662102},{"date":"2026-08-07","current":-23.782199,"twenty":-15.3547,"median":-11.807302,"eighty":-9.155597,"marketCap":42053706148},{"date":"2026-08-14","current":-24.484716,"twenty":-15.366538,"median":-11.807302,"eighty":-9.155597,"marketCap":43295956436},{"date":"2026-08-21","current":-25.66471,"twenty":-15.421639,"median":-11.807302,"eighty":-9.155597,"marketCap":45382521465},{"date":"2026-08-28","current":-26.805916,"twenty":-15.549054,"median":-11.807302,"eighty":-9.155597,"marketCap":47400498840},{"date":"2026-09-04","current":-25.559862,"twenty":-15.642968,"median":-11.807302,"eighty":-9.155597,"marketCap":45197120463},{"date":"2026-09-11","current":-24.648352,"twenty":-15.644447,"median":-11.807302,"eighty":-9.155597,"marketCap":43585310600}],"updateTime":1789260410075},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RVMD\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658950539","title":"百濟神州與Revolution Medicines宣佈合作；甘李藥業宣佈減肥新藥海外BD | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2658950539","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658950539?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 07:01","pubTimestamp":1786402877,"startTime":"0","endTime":"0","summary":"丨2026年8月11日星期二丨NO.1百济神州与RevolutionMedicines宣布达成临床开发及区域商业化合作8月10日，百济神州宣布与全球专注癌症药物研发的生物科技公司RevolutionMedicines达成一项多方面合作协议，涵盖临床联合开发与区域商业化授权两大核心板块，旨在加速RAS驱动型癌症的创新疗法研发与市场落地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608113837029212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608113837029212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","IE00BJJMRZ35.SGD","LU0109394709.USD","603087","RVMD","IE00BJT1NW94.SGD","LU1251922891.USD","KURE","BK4526","BK1515","LU0889565916.HKD","IE0002141913.USD","159938","ONC","09939","IE00BFTCPJ56.SGD","LU0320765992.SGD","BBH","BK1583","BD","BK0239","IE00B4R5TH58.HKD","BK4588","688235","LU0588546209.SGD","LU1719994722.HKD","LU0307460666.USD","LU0228659784.USD","CANC","IE0009354923.USD","LU2328871848.SGD","BK1574","LU0828237510.HKD","IDNA","IE00B2B36J28.USD","LU1969619763.USD","LU1303224171.USD","BK1588","BK4139","IE0009355771.USD","PTH","BK1161","BK4585","BK1500","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189831237","title":"百濟神州獲Revolution Medicines四大資產在選定亞洲市場的獨家授權","url":"https://stock-news.laohu8.com/highlight/detail?id=1189831237","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189831237?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 18:05","pubTimestamp":1786356339,"startTime":"0","endTime":"0","summary":"百济神州（Beone Medicines Ltd.）宣布，已获得Revolution Medicines, Inc.旗下四项核心资产在特定亚洲市场的独家权利。这一战略合作，标志着百济神州在亚洲关键区域的布局进一步深化。\n依据协议，百济神州将独家享有Revolution Medicines这四款创新药物在部分亚洲国家和地区的开发、商业化权益。此举不仅丰富了百济神州的肿瘤产品管线，也为其在亚洲市场的竞争力增添了强劲动力。交易的财务细节尚未披露，但市场分析人士普遍认为，此举对双方而言都是互利共赢的明智选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0889565916.HKD","IDNA","IE0002141913.USD","BK0239","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0009354923.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","CANC","LU0320765992.SGD","IE00BJT1NW94.SGD","BBH","RVMD","BK4139","688235","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142470173","title":"百濟神州與Revolution Medicines合作：里程碑付款與分級版税權益","url":"https://stock-news.laohu8.com/highlight/detail?id=1142470173","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142470173?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 18:04","pubTimestamp":1786356295,"startTime":"0","endTime":"0","summary":"百济神州（Beone Medicines Ltd.）与Revolution Medicines, Inc.已达成合作，根据协议，双方将在合作区域内享有获得里程碑付款及分级版税的权利。这一安排标志着两家公司在共同开发与商业化方面迈出了重要一步，为各自带来了潜在的经济收益与战略协同。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","CANC","LU0109394709.USD","LU0320765992.SGD","PTH","BBH","BK0239","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4139","IE00B2B36J28.USD","IE0009355771.USD","688235","RVMD","IDNA","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657147096","title":"根據美國證券交易委員會文件披露，谷歌母公司Alphabet Inc.將其持有Revolution Medicines I","url":"https://stock-news.laohu8.com/highlight/detail?id=2657147096","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657147096?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 18:07","pubTimestamp":1786097238,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0052756011.USD","LU1923623000.USD","LU0820561818.USD","LU0943347566.SGD","LU1791710400.SGD","LU2417539215.USD","SG9999015952.SGD","LU0310800965.SGD","LU2213496289.HKD","LU0109394709.USD","LU2362541273.HKD","GXPC","LU2462157665.USD","SG9999018865.SGD","LU2505996681.GBP","LU0708994859.HKD","LU2168564149.EUR","LU0302445910.USD","LU1366333091.USD","LU0154236417.USD","LU1923622614.USD","LU0097036916.USD","LU0211326839.USD","BK4538","LU0077335932.USD","LU0477156953.USD","LU0289739343.SGD","LU0353189763.USD","LU1718418525.SGD","LU0094547139.USD","LU0354030438.USD","LU1323610961.USD","IE00BKPKM429.USD","LU0689626769.HKD","LU1267930227.SGD","BK4598","LU0345774391.USD","LU2023251221.USD","BK4550","BK4574","LU0143551892.USD","LU2065170008.USD","GGLS","IE00BD6J9T35.USD","LU1244550494.USD","LU1951198990.SGD","SGXZ44715902.SGD","LU0208291251.USD","GOU","SG9999015341.SGD","IE00BN8TJ469.HKD","LU0289960550.SGD","LU2403377893.USD","CMAG","LU2092627202.USD","LU0109391861.USD","LU1506573853.SGD","IE00BKVL7J92.USD","BK4077","LU2404859667.USD","LU1917777945.USD","LU0689472784.USD","LU0265550359.USD","IE00B19Z8X17.USD","LU2125909593.SGD","IE00BK4W5L77.USD","IE000F7OJYX1.SGD","IE0000B7K699.USD","LU0070217475.USD","LU1221951046.USD","BK4139","LU1868837136.USD","IE00BJT1NW94.SGD","LU0353189680.USD","LU1145028129.USD","SG9999015358.SGD","IE00BQXX3F31.USD","SG9999018857.SGD","LU1244550577.SGD","LU1674673428.USD","LU0868494708.USD","LU0203347892.USD","HK0000914660.USD","GOOGL","LU2746668974.SGD","LU1196500208.SGD","LU1202635105.USD","LU1803068623.USD","LU0345769631.USD","LU0124676726.USD","LU0823421333.USD","LU2360032135.SGD","LU1235294995.USD","LU2111349929.HKD","LU2065171402.SGD","IE000BZT7R73.USD","LU1670756490.USD","LU0784385170.HKD","LU0476273544.USD","LU0157215616.USD","GOOY","LU1066053197.SGD","IE000MB6IJN5.SGD","CQTM","LU0211327993.USD","LU0211328371.USD","LU2471134952.CNY","GB00B4QBRK32.GBP","LU0056508442.USD","LU0316494557.USD","LU0472753341.HKD","LU1571399168.USD","LU2250418816.HKD","LU0496365809.HKD","LU2362541513.USD","LU2065171311.SGD","LU0640476718.USD","LU0784383803.USD","LU0964807845.USD","XDAT","BK4527","LU0011850046.USD","IE00BDCRKT87.USD","LU2433249047.HKD","LU0158827781.USD","LU0784384876.USD","SG9999014559.SGD","IE00B7SZLL34.SGD","LU2097344357.USD","IE00BHPRN162.USD","LU2756315664.SGD","IE0002141913.USD","LU2471134796.USD","LU0057025933.USD","IE00BJJMRZ35.SGD","LU0061475181.USD","LU1201861165.SGD","LU0130103400.USD","LU0348723411.USD","LU1894683348.USD","LU2381873111.SGD","LU1989772840.SGD","LU1548497426.USD","LU2954938101.SGD","LU2264538146.SGD","SG9999015945.SGD","LU1280957306.USD","SG9999014567.USD","LU2756315318.SGD","LU1642822529.SGD","LU1988902786.USD","BK4543","LU0672654240.SGD","LU1674673691.USD","IDNA","LU1303367103.USD","LU1670627923.USD","IE00BLSP4452.SGD","LU1267930573.SGD","GOOP","LU1429558221.USD","LU0234570918.USD","LU0994945656.USD","LU2028103732.USD","LU0080751232.USD","LU0127658192.USD","SG9999015978.USD","LU0149725797.USD","LU2404859741.USD","LU2247934214.USD","LU0345770993.USD","LU1043141396.HKD","LU0345769128.USD","LU0976567544.SGD","LU1935042488.USD","BK4612","LU0187121727.USD","LU1935043536.SGD","LU0511384066.AUD","LU2237438978.USD","SGXZ51526630.SGD","LU0528227936.USD","LU1119994496.HKD","LU0444973449.USD","LU1645745479.HKD","GOOW","IE0034235295.USD","LU2125909247.SGD","SG9999015986.USD","LU2168564495.EUR","LU0942090050.USD","LU1267930813.SGD","IE00BMPRXN33.USD","LU0267386448.USD","LU1496350502.SGD","LU2462591277.SGD","LU0882574139.USD","LU1868836591.USD","LU0107464264.USD","LU1791710582.SGD","LU2491049909.HKD","IE0034235188.USD","LU0792757196.USD","HK0000304805.HKD","LU0130102774.USD","LU0312595415.SGD","LU2098885051.SGD","LU0426417589.USD","LU2211815571.USD","LU1301847155.USD","LU1201861249.SGD","LU1974910355.USD","LU1066051225.USD","LU0265550946.USD","LU2357305700.SGD","LU0889565916.HKD","LU1153585028.USD","LU2087625088.SGD","IE00B1BXHZ80.USD","LU0251142724.SGD","LU0823434740.USD","BK4602","IE00BQXX3C00.GBP","LU1880398471.USD","LU2242649171.HKD","LU0048584097.USD","SG9999017495.SGD","TRUC","BK4585","LU2275660780.HKD","LU0738911758.USD","LU2065169927.USD","IE00BJTD4V19.USD","LU0069063385.USD","LU0949170772.SGD","BK4576","LU1267930490.SGD","LU0557290698.USD","LU1868837300.USD","IE00BWXC8680.SGD","LU2750360641.GBP","IE00B19Z3581.USD","LU0130518102.USD","LU2491050071.SGD","IE00BFMHRM44.USD","XLC","GB00B4LPDJ14.GBP","LU1868836757.USD","LU0323591593.USD","HK0000532082.HKD","OGIG","LU0289961442.SGD","LU0823421416.USD","LU2236285917.USD","BK4579","LU0444971666.USD","LU2023250843.SGD","LU2750360997.AUD","BK4592","IE0009354923.USD","LU0198837287.USD","LU0320765992.SGD","LU0477156797.USD","SNPE","BK4532","LU1116320737.USD","LU0310800379.SGD","HK0000819398.USD","SG9999014906.USD","LU1699723380.USD","LU2860962120.EUR","LU0545039389.USD","LU1116320901.HKD","SG9999014880.SGD","LU0170899867.USD","LU1059921491.USD","LU1121112475.USD","LU0048573561.USD","LU0985320562.USD","LU1633808545.USD","LU0345768153.USD","IE00BMPRXQ63.HKD","LU0648001328.SGD","LU0889566641.SGD","LU1003077747.HKD","LU1823568750.SGD","LU1852331112.SGD","LU0345768740.USD","LU2106854487.HKD","IE00BJLML261.HKD","IE00BJTD4N35.SGD","LU1935042991.SGD","LU0784385840.USD","LU2244417387.USD","IE0004086264.USD","LU0251131958.USD","LU2456880835.USD","LU0683600562.USD","LU0251132253.USD","LU1064131342.USD","LU2097344431.USD","LU2092937148.SGD","LU1551013342.USD","LU2168563687.JPY","LU1267930730.SGD","LU1496350171.SGD","SKYY","BBH","BK4561","LU0820562030.AUD","LU1720051017.SGD","SGXZ31699556.SGD","LU2420271590.USD","LU0320765059.SGD","LU2242650005.HKD","IE00BKDWB100.SGD","LU0314106906.USD","IE0002270589.USD","BK4566","LU0310799852.SGD","LU0138981039.USD","EFIV","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0553294199.USD","LU0128525929.USD","LU1815336760.USD","IE0034235303.USD","LU1935042215.USD","LU1084165304.USD","IE00BBT3K403.USD","LU2430703178.SGD","LU0096364046.USD","LU0096362180.USD","LU1989772923.USD","LU0174119429.USD","LU1032955483.USD","LU2462591350.SGD","LU1400636574.HKD","LU0215105999.USD","LU1261432733.SGD","IE00B4R5TH58.HKD","LU1935043023.USD","IE00B1XK9C88.USD","LU0417517546.SGD","GOOX","LU1804176565.USD","LU1400636657.SGD","IE00B19Z8W00.USD","LU0742534661.SGD","LU1914381329.SGD","LU2168564065.EUR","LU1046421795.USD","LU1221951129.SGD","IE00B19Z9505.USD","LU2089283258.USD","LU1629891620.HKD","IE0004091025.USD","LU0061474705.USD","LU0648000940.SGD","LU0276348264.USD","LU2430703095.HKD","LU0868494617.USD","LU1839511570.USD","IE000WAW04H5.SGD","LU1244550221.USD","LU0426412945.USD","LU2999663052.SGD","IE00BQXX3D17.EUR","LU2471134879.HKD","LU1989764664.SGD","LU0128525689.USD","IE00BDRTCR15.USD","LU0957808578.USD","LU0823434583.USD","BK4514","LU1366192091.USD","LU1894683264.USD","LU0070302665.USD","IE0001KFT4U8.USD","GGLL","IE000SO60NU8.SGD","LU1951200564.SGD","SG9999014575.USD","LU1430594728.SGD","LU1400636491.USD","IE00BYXW3230.USD","LU1815333072.USD","IE00BMPRXR70.SGD","LU2362540622.SGD","LU2471134523.USD","LTL","LU2168564222.USD","LU1551013425.SGD","LU2602419157.SGD","LU2191332357.HKD","LU0203345920.USD","LU0225283273.USD","IE00BLSP4239.USD","LU0690374961.EUR","IE00BZ1G4Q59.USD","SGXZ99366536.SGD","LU2023250330.USD","LU0787776722.HKD","BK4573","LU1316542783.SGD","SG9999014898.SGD","BK4581","LU0211326755.USD","LU0006306889.USD","LU0210533765.USD","LU0061474960.USD","LU1868836914.USD","LU2271345857.HKD","LU0211331839.USD","LU0820561909.HKD","LU2505996509.AUD","LU0980610538.SGD","HK0000304797.USD","BK4503","LU1043141123.HKD","IE0009355771.USD","LU1435385759.SGD","LU1880398554.USD","LU0949170426.SGD","LU2023250504.SGD","VOX","LU0345774631.USD","LU2592432038.USD","LU1066051811.HKD","LU2125154935.USD","LU0029864427.USD","LU0494093205.USD","LU2430703251.USD","LU1066051498.USD","SG9999014542.SGD","LU0466842654.USD","LU1232071149.USD","LU0642271901.SGD","LU1720051108.HKD","LU0256863811.USD","LU2265009873.SGD","LU0158827948.USD","IE00BK4W5M84.HKD","LU0690374615.EUR","LU1670628061.USD","LU1989764748.USD","LU0320765489.SGD","LU1585245621.USD","PTH","LU2102340556.USD","BK4533","LU0342679015.USD","LU2326559502.SGD","RVMD","IE00BSNM7G36.USD","LU2054465674.USD","LU2097829019.USD","LU1778281490.HKD","LU0256863902.USD","LU0234572021.USD","IE00B19Z3B42.SGD","CANC","LU0106261372.USD","LU2491050154.USD","METV","HK0000914686.HKD","LU0314104364.USD","LU2125154778.USD","BK4588","LU2087621335.USD","LU2360106780.USD","LU0175139822.USD","LU0957791311.USD","LU2077746001.SGD","LU2089284900.SGD","LU0708995401.HKD","SG9999014914.USD","FCOM","ILDR","SG9999000418.SGD","LU0345770308.USD","LU0661504455.SGD","BK4534","SGXZ81514606.USD","LU0354030511.USD","LU2746668461.USD","LU2063271972.USD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657591579","title":"Revolution Medicines 2026年第二季度財報：研發投入推高淨虧損","url":"https://stock-news.laohu8.com/highlight/detail?id=2657591579","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657591579?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 05:18","pubTimestamp":1785964730,"startTime":"0","endTime":"0","summary":"Revolution Medicines 2026年第二季度净亏损扩大至$644.4 million，每股亏损$3.06，期末现金达$3.9 billion；daraxonrasib新药申请获FDA受理。","market":"nz","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock2.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock2.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/earnings/262079651-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","PSET","SQMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125314601","title":"異動解讀｜Revolution Medicines盤中上漲5.23%，FDA受理新藥申請疊加財報前市場預期升温","url":"https://stock-news.laohu8.com/highlight/detail?id=1125314601","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125314601?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 00:35","pubTimestamp":1785861308,"startTime":"0","endTime":"0","summary":"8月5日，Revolution Medicines盘中上涨5.23%，报191.99美元/股，成交额9810.16万美元。消息面上，FDA此前已正式受理公司核心管线药物Daraxonrasib用于既往治疗过的转移性胰腺癌的新药上市申请（NDA），标志关键监管里程碑。同时欧洲药品管理局亦启动分阶段审评加速评估。Wedbush将目标价上调至192.10美元并维持跑赢大盘评级。此外，公司当日盘后将发布季度财报，市场对RAS靶向药物商业化前景预期持续升温，多重催化剂共振推动股价上行。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656325798","title":"傑富瑞因索馬圖林面臨的競爭風險，將伊普森評級下調至「表現遜於大盤」","url":"https://stock-news.laohu8.com/highlight/detail?id=2656325798","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656325798?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 15:01","pubTimestamp":1785740464,"startTime":"0","endTime":"0","summary":"BUZZ-杰富瑞因索马图林面临的竞争风险，将伊普森评级下调至“表现逊于大盘”8月3日-** 杰富瑞将法国制药公司伊普森的评级从“中性”下调至“表现逊于大盘”，理由是其Somatuline药物面临长期风险** 该券商预测，受仿制药竞争以及卡穆鲁斯公司带来的压力增大影响，Somatuline在2027年的销售额将下滑20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4S4400GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","PTH","CANC","IE00B4R5TH58.HKD","IE0009354923.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0109394709.USD","RVMD","BK4139","IE0009355771.USD","IE00BFTCPJ56.SGD","IDNA","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131945806","title":"異動解讀｜Revolution Medicines盤中上漲5.02%，FDA受理胰腺癌新藥上市申請疊加投行上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1131945806","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131945806?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 03:12","pubTimestamp":1785438771,"startTime":"0","endTime":"0","summary":"7月31日，Revolution Medicines盘中上涨5.02%，报190.0美元/股，成交额2.3亿美元。消息面上，FDA已正式受理公司提交的Daraxonrasib新药上市申请，用于治疗既往接受过治疗的转移性胰腺癌患者，标志着药物进入实质性审评阶段。同时，Wedbush将公司目标价由181美元上调至192.10美元，维持\"跑赢大盘\"评级，分析师共识均价达203.85美元。此前该药物三期试验数据显示，中位总生存期延长一倍至13.2个月，欧洲药品管理局亦已启动分阶段加速审评，全球商业化前景进一步明朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117561795","title":"異動解讀｜Revolution Medicines盤中上漲5.06%，核心藥物NDA獲FDA正式受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1117561795","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117561795?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 22:24","pubTimestamp":1784816691,"startTime":"0","endTime":"0","summary":"7月23日，Revolution Medicines盘中上涨5.06%，报192.3美元/股，成交额1.06亿美元。消息面上，FDA已正式受理公司核心候选药物Daraxonrasib的新药上市申请，适应症为既往接受过治疗的转移性胰腺癌。该受理标志着关键监管里程碑，意味着FDA已启动实质性审评流程。同日，Wedbush将公司目标价从181美元上调至192.10美元，维持\"跑赢大盘\"评级。Revolution Medicines成立于2014年，是一家临床阶段精准肿瘤学公司，专注于开发靶向RAS成瘾癌症的创新疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178535518","title":"Revolution Medicines新藥Daraxonrasib獲FDA受理，用於既往治療過的轉移性胰腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1178535518","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178535518?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 04:06","pubTimestamp":1784750800,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式受理Revolution Medicines, Inc.提交的新药上市申请（NDA），该申请旨在寻求批准其候选药物Daraxonrasib用于治疗既往接受过治疗的转移性胰腺癌患者。\n这一受理标志着该药物研发进程中的一个关键监管里程碑，意味着FDA已认定申请材料完整，并已启动实质性的审评流程。胰腺癌，尤其是转移性疾病，长期以来预后不佳，治疗选择有限，因此这一新疗法的审评进展备受业界关注。\n公司股价在消息公布后反应积极，市场正密切关注后续的审评时间表以及可能的批准前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","CANC","BBH","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","IE00B2B36J28.USD","PTH","IDNA","IE0002141913.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE0009354923.USD","BK4139","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136893445","title":"異動解讀｜Revolution Medicines盤前下跌5.11%，報172.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136893445","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136893445?lang=zh_tw&edition=fundamental","pubTime":"2026-07-17 16:32","pubTimestamp":1784277142,"startTime":"0","endTime":"0","summary":"7月17日，Revolution Medicines盘前下跌5.11%，报172.36美元/股，成交额4.49万美元。Revolution Medicines所在的生物科技行业中，个股中，艾伯维公司涨0.88%，吉利德科学涨0.72%，安进涨0.84%，福泰制药涨0.41%，再生元制药公司涨0.72%。Revolution Medicines是一家临床阶段的精准肿瘤学公司，专注于开发靶向疗法以抑制RAS成瘾癌症。公司核心管线daraxonrasib此前在转移性胰腺癌三期试验中展现显著总生存期获益，目前已进入EMA分阶段审评及FDA申报准备阶段，公司正积极搭建全球自主商业化团队。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175603747","title":"歐洲藥品管理局啓動分階段審評，加速評估Revolution Medicines的Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=1175603747","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175603747?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 21:30","pubTimestamp":1783431047,"startTime":"0","endTime":"0","summary":"欧洲药品管理局已决定通过分阶段审评程序，加快对Revolution Medicines, Inc.（股票简称：RVMD）旗下在研药物Daraxonrasib的评估进程。此举旨在缩短该潜在疗法的审评时间，使其能更早惠及患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","RVMD","IE0002141913.USD","IE00B2B36J28.USD","IDNA","LU0320765992.SGD","PTH","CANC","IE00B4R5TH58.HKD","BBH","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649938851","title":"歐洲藥品管理局（EMA）對Revolution Medicines實驗性胰腺癌口服藥啓動滾動審查","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938851","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649938851?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 21:07","pubTimestamp":1783429668,"startTime":"0","endTime":"0","summary":"欧洲药品管理局对Revolution Medicines实验性胰腺癌口服药启动滚动审查路透7月7日-欧洲药品管理局周二表示，已开始对Revolution Medicines公司针对转移性胰腺癌患者的实验性疗法RVMD.O进行滚动审查。今年5月，美国食品药品监督管理局批准了Revolution Medicines公司针对既往接受过治疗的胰腺癌患者的口服药物，允许其在获得监管批准前进行早期使用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T43915N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BBH","IE00B2B36J28.USD","IE0002141913.USD","BK4139","IE0009355771.USD","CANC","IDNA","LU0320765992.SGD","LU0109394709.USD","RVMD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649980277","title":"歐盟監管機構開始對一種抗癌藥物進行分階段審查，Revolution Medicines股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980277","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649980277?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 21:00","pubTimestamp":1783429252,"startTime":"0","endTime":"0","summary":"BUZZ-欧盟监管机构开始对一种抗癌药物进行分阶段审查，Revolution Medicines股价上涨7月7日-** 生物技术公司Revolution Medicines（RVMD.O）的股价在盘前交易中上涨1.3%，至192.42美元** 欧洲药品管理局表示，其人类药品专家委员会已开始对Revolution Medicines用于治疗转移性胰腺癌的试验性药物daraxonrasib进行分阶段审","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T439159:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","PTH","IE00B4R5TH58.HKD","RVMD","CANC","LU0109394709.USD","IDNA","IE00BFTCPJ56.SGD","BBH","IE00BJT1NW94.SGD","IE0009355771.USD","LU0889565916.HKD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155723179","title":"異動解讀｜Revolution Medicines盤中上漲5.07%，ESMO GI數據亮眼疊加收入預期上調","url":"https://stock-news.laohu8.com/highlight/detail?id=1155723179","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155723179?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 03:39","pubTimestamp":1782761955,"startTime":"0","endTime":"0","summary":"6月30日，Revolution Medicines盘中上涨5.07%，报191.32美元/股，成交额7.69亿美元。消息面上，公司在欧洲肿瘤内科学会胃肠道肿瘤年会上披露最新临床数据，第二款RAS抑制剂zoldonrasib联合标准化疗在一线胰腺癌中客观缓解率达82%，zoldonrasib联合daraxonrasib的无化疗方案二线治疗ORR达50%，数据大超预期。此前瑞银指出，若双药联合数据积极，公司胰腺癌收入有望提升20%至40%，并预计daraxonrasib将快速获批上市。此外，公司已启动Rasolute 305三期试验患者治疗，进一步拓展一线治疗布局。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137657818","title":"異動解讀｜Revolution Medicines盤中上漲5.91%，啓動Zoldonrasib聯合化療一線胰腺癌三期試驗疊加投行看好收入增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1137657818","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137657818?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 22:28","pubTimestamp":1782397724,"startTime":"0","endTime":"0","summary":"6月25日，Revolution Medicines盘中上涨5.91%，报181.15美元/股，成交额2.2亿美元。消息面上，公司于6月23日宣布正式启动Rasolute 305三期临床试验的患者治疗工作，评估Zoldonrasib联合化疗作为RAS G12D突变型转移性胰腺癌一线疗法。此外，瑞银于6月22日发布研报指出，若Zoldonrasib与Daraxonrasib双药联合数据积极，公司胰腺癌收入有望提升20%至40%，并期待二线联合用药应答率超过40%。公司核心产品Daraxonrasib此前已在Rasolute 302三期试验中展示总生存期翻倍的突破性数据，目前正推进FDA审批。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121703894","title":"Revolution Medicines啓動Rasolute 305患者治療，評估Zoldonrasib聯合化療作為Ras G12d轉移性胰腺癌一線療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1121703894","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121703894?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 20:00","pubTimestamp":1782216055,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc. 已正式启动其名为Rasolute 305的三期临床试验的患者治疗工作。这项关键性研究旨在评估其候选药物Zoldonrasib与化疗联合方案，作为Ras G12d突变型转移性胰腺癌患者一线治疗的有效性与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU0889565916.HKD","IE0002141913.USD","RVMD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645987094","title":"媒體-抗癌藥物製造商Revolution Medicines表示，出售公司並非當務之急——《金融時報》","url":"https://stock-news.laohu8.com/highlight/detail?id=2645987094","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645987094?lang=zh_tw&edition=fundamental","pubTime":"2026-06-21 12:08","pubTimestamp":1782014895,"startTime":"0","endTime":"0","summary":"媒体-抗癌药物制造商Revolution Medicines表示，出售公司并非当务之急——《金融时报》6月21日 - -- 来源链接： https://tinyurl.com/3fe4zppp-- 注：路透尚未核实此报道，也不对其准确性负责(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260621:nL4S42T007:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","RVMD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4139","IE00BJT1NW94.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0109394709.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645094982","title":"媒體-抗癌藥物製造商Revolution Medicines表示，出售公司並非當務之急——《金融時報》","url":"https://stock-news.laohu8.com/highlight/detail?id=2645094982","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645094982?lang=zh_tw&edition=fundamental","pubTime":"2026-06-21 12:08","pubTimestamp":1782014895,"startTime":"0","endTime":"0","summary":"媒体-抗癌药物制造商Revolution Medicines表示，出售公司并非当务之急——《金融时报》6月21日 - -- 来源链接： https://tinyurl.com/3fe4zppp-- 注：路透尚未核实此报导，也不对其准确性负责(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260621:nL4T42T007:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0109394709.USD","IE0002141913.USD","RVMD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4139","IE00B4R5TH58.HKD","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167442691","title":"異動解讀｜Revolution Medicines盤中下跌5.21%，報142.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167442691","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167442691?lang=zh_tw&edition=fundamental","pubTime":"2026-06-10 23:23","pubTimestamp":1781104981,"startTime":"0","endTime":"0","summary":"6月10日，Revolution Medicines盘中下跌5.21%，报142.19美元/股，成交额1.28亿美元。Revolution Medicines所在的生物科技行业中，个股中，吉利德科学跌2.1%，Nuvalent涨0.1%，安进涨0.85%，艾伯维公司涨0.66%，Argenx SE跌0.06%。Revolution Medicines是一家临床阶段精准肿瘤学公司，专注于开发靶向RAS成瘾癌症的创新疗法，拥有基于结构的药物发现能力及针对RAS通路关键信号节点的深层管线。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":88,"code":"91000000","status":"200"}]}}